文献速递母胎医学产科

胎儿脊髓脊膜膨出修复术后绒毛膜羊膜分离:发生率、危险因素及对围产结局的影响

Chorioamniotic membrane separation following fetal myelomeningocele repair: incidence, risk factors and impact on perinatal outcome.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

这项回顾性队列研究纳入91例胎儿脊髓脊膜膨出修复术病例,绒毛膜羊膜分离(CAS)发生率为34.1%。前壁胎盘是胎儿镜修复术后CAS的唯一危险因素(OR 3.72),CAS显著增加胎膜早破(OR 7.6)和早产(OR 3.2)风险。

要点

  • 胎儿脊髓脊膜膨出修复术后CAS发生率为34.1%(31/91)。
  • 前壁胎盘增加胎儿镜修复术后CAS风险(OR 3.72),开放手术中无显著关联。
  • CAS增加胎膜早破(OR 7.6)和早产(OR 3.2)风险,胎儿镜修复组中更显著。

核心结论

  • 前壁胎盘是胎儿镜脊髓脊膜膨出修复术后CAS的唯一危险因素。
  • 胎儿镜修复术后检测到CAS显著增加胎膜早破和早产风险。

研究设计与样本

  • 回顾性队列研究,纳入2011年11月至2018年12月间接受胎儿脊髓脊膜膨出修复术的患者91例。
  • 手术方式为胎儿镜(经腹或外置子宫)或开放子宫切开术,纳入标准参照Management of Myelomeningocele Study。
  • CAS严重程度按羊膜剥离范围分级:轻度<25%宫腔,中度25-50%,重度>50%。

主要发现

  • CAS总发生率为34.1%(31/91),诊断中位孕周28.1周(范围24.4-37.6周)。
  • 前壁胎盘是CAS的危险因素(OR 3.72,95%CI 1.46-9.5;P<0.01),该风险依赖于修复技术:胎儿镜修复组OR 3.94(95%CI 1.14-13.6;P=0.03),开放修复组OR 2.8(95%CI 0.6-12.5;P=0.16)。
  • 胎儿镜修复组与开放修复组CAS发生率无显著差异(40.4% vs 25.6%;P=0.14),CAS诊断孕周、手术至诊断间隔、严重程度分布及进展在两组间亦无差异。
  • CAS增加胎膜早破风险(有CAS者50% vs 无CAS者12%;OR 7.6,95%CI 2.5-21.9;P<0.01)和早产风险(70% vs 38%;OR 3.2,95%CI 1.3-8.1;P<0.01)。
  • 胎儿镜修复组中,合并CAS者胎膜早破率(60.0% vs 6.5%;P<0.01)和早产率(65.0% vs 16.1%;P<0.01)高于无CAS者;开放修复组中差异无统计学意义。

临床怎么用

  • 胎儿脊髓脊膜膨出修复术后应警惕CAS发生,尤其前壁胎盘接受胎儿镜修复的病例。
  • 胎儿镜修复术后检出CAS者需加强胎膜早破和早产监测。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Prenatal myelomeningocele (MMC) repair has been shown to provide significant benefits to the infant, decreasing the postnatal need for ventriculoperitoneal shunt and improving motor outcome. Chorioamniotic membrane separation (CAS) is a potential complication following prenatal MMC repair and may increase the risk of preterm prelabor rupture of membranes (PPROM) and preterm birth. The objectives of this study were: (1) to evaluate the incidence of CAS after prenatal MMC repair; (2) to determine risk factors associated with its occurrence; and (3) to assess its association with adverse perinatal outcomes. METHODS: This was a retrospective cohort study of patients who underwent fetal MMC repair between November 2011 and December 2018. Surgery was performed using either a fetoscopic (laparotomy or exteriorized uterus) approach or an open-hysterotomy approach. Eligibility criteria were those reported in the Management of Myelomeningocele Study. If CAS was detected on ultrasound (US), its severity was graded as 'mild' if amnion detachment involved < 25% of the uterine cavity, 'moderate' if it involved 25-50% and 'severe' if it involved > 50%. Evolution of CAS was classified as stable, increasing or decreasing based on the difference in severity grading between the time at first diagnosis and the last US scan before delivery. Logistic regression analysis was performed to identify pre- or perisurgical factors associated with the development of CAS and to determine the risk of adverse perinatal outcome associated with CAS. RESULTS: In total, 91 cases were included. Fetoscopic or open-hysterotomy repair of MMC was performed in 52/91 (57.1%) and 39/91 (42.9%) cases, at a median gestational age (GA) of 25.0 weeks (range, 22.9-26.0 weeks) and 25.0 weeks (range, 21.3-25.9 weeks), respectively. CAS was diagnosed in 31/91 (34.1%) patients, at a median GA of 28.1 weeks (range, 24.4-37.6 weeks). Anterior placenta was identified as a risk factor for the postoperative development of CAS (odds ratio (OR), 3.72 (95% CI, 1.46-9.5); P < 0.01). This risk was dependent on the repair technique. An anterior placenta significantly increased the risk of CAS after fetoscopic repair (OR, 3.94 (95% CI, 1.14-13.6); P = 0.03) but not after open repair (OR, 2.8 (95% CI, 0.6-12.5); P = 0.16). There was no significant difference in the rate of CAS after fetoscopic repair (21/52 (40.4%)) vs open-hysterotomy repair (10/39 (25.6%)) (P = 0.14), nor were there any differences in GA at diagnosis of CAS, interval between surgery and diagnosis, distribution of CAS severity or progression of CAS between the two groups. CAS increased the risk of PPROM (50% in those with vs 12% in those without CAS) (OR, 7.6 (95% CI, 2.5-21.9); P < 0.01) and preterm delivery (70% vs 38%) (OR, 3.2 (95% CI, 1.3-8.1); P < 0.01). Fetoscopically repaired cases with CAS had a higher rate of PPROM (12/20 (60.0%) vs 2/31 (6.5%); P < 0.01) and preterm delivery (13/20 (65.0%) vs 5/31 (16.1%); P < 0.01) than those that did not develop CAS, while the differences were not significant in cases with open-hysterotomy repair. Early detection of CAS (before 30 weeks' gestation) was a risk factor for preterm delivery (90% before 30 weeks vs 36% at or after 30 weeks) (OR, 15.7 (95% CI, 2.3-106.3); P < 0.01). There was no association between PPROM or preterm delivery and the severity or progression of CAS. CONCLUSIONS: The presence of an anterior placenta was the only factor that increased the risk for CAS after fetoscopic MMC repair. Detection of CAS after fetoscopic MMC repair significantly increases the risk for PPROM and preterm delivery. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Corroenne R, Yepez M, Barth J, et al. Chorioamniotic membrane separation following fetal myelomeningocele repair: incidence, risk factors and impact on perinatal outcome. Ultrasound Obstet Gynecol. 2020. PMID: 31841246. doi:10.1002/uog.21947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。